In this video Thomas Wisniewski, MD, director of NYU Langone’s Alzheimer’s Disease Research Center, discusses recent advancements in Alzheimer's disease care.

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

The scientists concluded that while the two markers perform similarly, they yield complementary information, and sequential ...

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based ...

New blood test developed by researchers can not only detect Alzheimer’s disease but also determine its stage, helps ...

The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed ...

The results suggested that plasma MTBR-tau243 could help estimate the tauopathy load in Alzheimer's disease, improving ...

The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...